Abstract:We repaired exon 3 deletions of parkin in induced pluripotent stem cells (iPSCs) from a Parkinson's disease (PD) patient and introduced the PD‐linked A82E mutation to normal iPSCs. Parkin mutations are sufficient and necessary to reduce the frequency of pacemaking APs in A9 dopaminergic neurons differentiated from these iPSCs. Background The degeneration of nigral (A9) dopaminergic (DA) neurons results in cardinal motor symptoms that define Parkinson's disease (PD). Loss‐of‐function mutations in parkin are linked to a rare form of early‐onset PD that is inherited recessively. Objective We generated isogenic human A9 DA neurons with or without parkin mutations to establish the causal relationship between parkin mutations and the dysfunction of human A9 DA neurons. Methods Using TALEN (transcription activator‐like effector nuclease)‐ or CRISPR/Cas9‐mediated gene targeting, we produced two isogenic pairs of naivetropic induced pluripotent stem cells (iPSCs) by repairing exon 3 deletions of parkin in iPSCs derived from a PD patient and by introducing the PD‐linked A82E mutation into iPSCs from a healthy subject. The four lines of isogenic iPSCs were differentiated to A9 DA neurons, which fired spontaneous pacemaking action potentials (AP) dependent on L‐type Ca2+ channels. Results The frequency of the pacemaking APs was significantly reduced by parkin mutations introduced to normal neurons. Consistent with this, isogenic repair of parkin mutations significantly increased the frequency from that observed in patient‐derived neurons. Conclusions The results show that parkin maintains robust pacemaking in human iPSC‐derived A9 DA neurons. The function is critical to normal DA transmission required for controlling voluntary locomotor activities. © 2023 International Parkinson and Movement Disorder Society.

Generation of induced pluripotent stem cells (NIMHi015-A) from a Parkinson's Disease patient harbouring a homozygous Exon 3 deletion in the PRKN gene

Generation of an induced pluripotent stem cell line (HMSCATi004-A) from an early onset Parkinson's disease patient with PRKN gene mutation

Generation of naivetropic induced pluripotent stem cells from Parkinson's disease patients for high efficiency genetic manipulation

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease

Generation of an Induced Pluripotent Stem Cell Line (Gibhi003-A) from a Parkinson's Disease Patient with Mutant PINK1 (p. I368N).

Parkin Mutation Decreases Neurite Complexity and Maturation in Neurons Derived from Human Fibroblasts

Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations

Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation

Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation

iSCORE-PD: an isogenic stem cell collection to research Parkinson’s Disease

Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells

Parkin Controls Dopamine Utilization in Human Midbrain Dopaminergic Neurons Derived from Induced Pluripotent Stem Cells

Generation of induced pluripotent stem cell line (ZZUi027-A) derived from skin fibroblasts from a Parkinson's disease patient with RAB39B gene mutation

Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease

Generation of a PARK2 Homozygous Knockout Induced Pluripotent Stem Cell Line (Gibhi002-a-1) with Two Common Isoforms Abolished.

Generation of TWO G51D SNCA missense mutation iPSC lines (CRICKi011-A, CRICKi012-A) from two individuals at risk of Parkinson's disease

Generation of a human iPSC line from a Parkinson's disease patient with a novel CHCHD2 mutation (R145Q)

Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's disease

Parkin Maintains Robust Pacemaking in Human Induced Pluripotent Stem Cell‐Derived A9 Dopaminergic Neurons

Generation of a Human Ipsc Line from a Parkinson’s Disease Patient with a Novel CHCHD2 Mutation (P.r145q)